The Role of Complex Karyotype in the Diagnosis of Chronic Lymphocytic Leukemia: Integration of Conventional Cytogenetics and FISH Analysis

Authors

  • Irene Caliendo ASL SALERNO
  • Francesco Puopolo Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Carmela Fabbricatore Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Valeria Belsito Petrizzi Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Giuseppe Malfera' Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Maria Langella Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Catello Califano Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Abstract

Complex karyotype (CK) is an emerging high-risk feature in chronic lymphocytic leukemia (CLL). We evaluated its diagnostic and prognostic relevance by integrating conventional cytogenetic analysis (CCA) and fluorescence in situ hybridization (FISH) in 30 patients. CCA identified CK in 23% of cases, including high-complexity profiles (≥5 abnormalities). FISH detected recurrent genomic lesions with established prognostic value: del(13q), trisomy 12, del(11q), del(17p). Integrated analysis improved detection of genomic complexity and refined risk stratification beyond single-lesion assessment. A representative case highlighted the ability of combined approaches to identify high-risk CK with TP53 disruption. These findings support routine integration of CCA and FISH for comprehensive cytogenetic profiling in CLL.

Downloads

Download data is not yet available.

Author Biographies

Francesco Puopolo, Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Biologist. Medical Genetics Resident.

Professor and Head of Department of Medicine and Health Professions at the e-campus Salerno center, Salerno Formazione Business School.

Former Research Fellow in General Pathology at Salerno University.

Carmela Fabbricatore, Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Biologist. Clinical Biochemistry Specialist. Biologist Specialist at the Conventional and Molecular Cytogenetics Laboratory for Hematology-Oncology, P.O. “A. Tortora” Hospital, ASL Salerno.

Valeria Belsito Petrizzi, Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Medical Director, Hematology Specialist, P.O. “A. Tortora” Hospital. ASL Salerno.

Giuseppe Malfera', Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Biologist. Medicine and Surgery Student. Professor at Naples University and Former AIL researcher.

Maria Langella, Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Medical Director, Hematology Specialist. Head of Hematological Diagnostics, P.O. “A. Tortora”, ASL Salerno.

Catello Califano, Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Medical Director, Hematology Specialist. Head of Hematology Unit, P.O. “A. Tortora”, ASL Salerno.

References

Baliakas, P., Espinet, B., Mellink, C., Jarosova, M., Athanasiadou, A., Ghia, P., et al. (2022). Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations. HemaSphere, 6(4), e707. https://doi.org/10.1097/HS9.0000000000000707

Baliakas, P., Jeromin, S., Iskas, M., et al. (2019). Cytogenetic complexity in chronic lymphocytic leukemia: Definitions, associations, and clinical impact. Blood, 133(11), 1205–1216. https://doi.org/10.1182/blood-2018-10-881698

Brenner, H., Gondos, A., & Pulte, D. (2008). Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood, 111, 4916–4921. https://doi.org/10.1182/blood-2007-10-117879

Foà, R., Del Giudice, I., Guarini, A., et al. (2013). Clinical implications of the molecular genetics of chronic lymphocytic leukemia. Haematologica, 98(5), 675–685. https://doi.org/10.3324/haematol.2012.081828

Fürstenau, M., Thus, Y. J., Robrecht, S., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M., Dubois, J., et al. (2023). High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood, 142(5), 446–459. https://doi.org/10.1182/blood.2023019634

Haferlach, C., Dicker, F., Schnittger, S., Kern, W., & Haferlach, T. (2007). Comprehensive genetic characterization of CLL: A study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping. Leukemia, 21(12), 2442–2451. https://doi.org/10.1038/sj.leu.2404935

Kamaso, J., Puiggros, A., Salido, M., Melero, C., Rodríguez-Rivera, M., Gimeno, E., et al. (2024). Complex karyotype detection in chronic lymphocytic leukemia: A comparison of parallel cytogenetic cultures using TPA and IL2+DSP30 from a single center. Cancers, 16(12), 2258. https://doi.org/10.3390/cancers16122258

Kipps, T. J., Stevenson, F. K., Wu, C. J., Croce, C. M., Packham, G., Wierda, W. G., O’Brien, S., Gribben, J., & Rai, K. R. (2017). Chronic lymphocytic leukaemia. Nature Reviews Disease Primers, 3, 17008. https://doi.org/10.1038/nrdp.2017.8

Pekarsky, Y., & Croce, C. M. (2015). Role of miR-15/16 in CLL. Cell Death & Differentiation, 22(1), 6–11. https://doi.org/10.1038/cdd.2014.133

Redaelli, A., Laskin, B. L., Stephens, J. M., et al. (2004). The clinical and epidemiological burden of chronic lymphocytic leukaemia. European Journal of Cancer Care, 13, 279–287. https://doi.org/10.1111/j.1365-2354.2004.00470.x

Rigolin, G. M., Cavallari, M., Quaglia, F. M., Formigaro, L., Lista, E., Urso, A., et al. (2017). In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood, 129(26), 3495–3498. https://doi.org/10.1182/blood-2017-03-772285

Rigolin, G. M., Saccenti, E., Guardalben, E., Cavallari, M., Formigaro, L., Zagatti, B., et al. (2018). In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics. British Journal of Haematology, 181(2), 229–233. https://doi.org/10.1111/bjh.15174

Rose-Zerilli, M. J., Forster, J., Parker, H., et al. (2014). ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: Data from the UK LRF CLL4 trial. Haematologica, 99(4), 736–742. https://doi.org/10.3324/haematol.2013.098574

Serafin, A., Ruocco, V., Cellini, A., Angotzi, F., Bonaldi, L., Trentin, L., et al. (2025). Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype. British Journal of Haematology, 206(3), 832–841. https://doi.org/10.1111/bjh.19986

Visentin, A., Bonaldi, L., Rigolin, G. M., Mauro, F. R., Martines, A., Frezzato, F., et al. (2022). The complex karyotype landscape in chronic lymphocytic leukemia allows refinement of the risk of Richter syndrome transformation. Haematologica. https://doi.org/10.3324/haematol.2021.280720

Visentin, A., Bonaldi, L., Rigolin, G. M., Mauro, F. R., Martines, A., Frezzato, F., et al. (2019). The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia. British Journal of Cancer, 121(2), 150–156. https://doi.org/10.1038/s41416-019-0502-x

Wan, T. S. K. (2014). Cancer cytogenetics: Methodology revisited. Annals of Laboratory Medicine, 34(6), 443–449. https://doi.org/10.3343/alm.2014.34.6.443

Wan, T. S. K. (2017). Cancer cytogenetics: Methods and protocols. Humana Press.

Woyach, J. A., Furman, R. R., Liu, T. M., et al. (2014). Resistance mechanisms for the Bruton’s tyrosine kinase inhibitor ibrutinib. New England Journal of Medicine, 370, 2286–2294. https://doi.org/10.1056/NEJMoa1400026

Published

16-11-2026

How to Cite

Caliendo, I., Puopolo, F., Fabbricatore, C., Belsito Petrizzi, V., Malfera’, G., Langella, M., & Califano, C. (2026). The Role of Complex Karyotype in the Diagnosis of Chronic Lymphocytic Leukemia: Integration of Conventional Cytogenetics and FISH Analysis. International Journal of Health Sciences, 10(3). Retrieved from https://www.sciencescholar.us/journal/index.php/ijhs/article/view/16037

Issue

Section

Peer Review Articles